Modified · Business Segments

As of September 30, 2025, BD’s operations consistconsisted of three worldwide business segments: BD Medical, BD Life Sciences and BD Interventional. As is further described below, on September 3, 2024, BD completed its acquisition of Edwards Lifesciences’ Critical Care product group (“Critical Care”)discussed in Note 8 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data, which was renamed aseffective October 1, 2025, BD Advanced Patient Monitoring (“Advanced Patient Monitoring”) and operates as a separate organizational unit within the Company’s Medical segmentreorganized its organizational units into five distinct, separately-managed segments, based on the nature of BD’s product and service offerings. Information with respect to BD’s business BD’s new organizational structure is based upon the following five segments is included in Notes 8: Medical Essentials, Connected Care, BioPharma Systems, 11Interventional and 16, respectivelyLife Sciences, to the consolidated financial statements contained in Item 8. Financial Statements which remains a critical part of BD until the separation and combination of our Biosciences and Supplementary DataDiagnostic Solutions business with Waters Corporation (“Waters”), and is incorporated herein by referenceas further discussed below, is completed.